Physician profile
Ali Hasnie
NPI 1225561897
$28,952.21
in general payments reported to CMS, 2019-2025
30 companies · $5,511 in 2025
The $5,511 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2021: $1,128 · 2022: $5,070 · 2023: $7,649 · 2024: $9,481 · 2025: $5,511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,504 · Grant: $7,735 · Food and Beverage: $5,647 · Education: $606 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,503.93 |
| Grant | $7,735.04 |
| Food and Beverage | $5,647.20 |
| Education | $605.68 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,817.83 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, In.Pact Admiral |
| Boston Scientific Corporation | $6,163.85 | 2021-2025 | Versacross Access Solution, General - Catheter, Opticross |
| Inari Medical, INC. | $3,518.95 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $3,266.36 | 2022-2025 | Igt Devices Undivided, US Eq Undivided, Coronary Undivided |
| Penumbra, INC. | $2,516.55 | 2022-2025 | Indigo System |
| Abbott Laboratories | $1,096.27 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite Precision, Ensite |
| Cook Medical LLC | $594.26 | 2021-2023 | Cook |
| Acist Medical Systems, INC. | $416.89 | 2023-2024 | |
| Abiomed | $308.83 | 2023-2025 | Impella |
| W. L. Gore & Associates, INC. | $306.31 | 2022-2025 | Gore Cardioform Septal Occluder, Gore-Tex Vascular Graft |
| Irhythm Technologies, INC. | $299.10 | 2024 | Zio Monitor, Zio Xt Patch |
| Endologix LLC | $294.62 | 2024-2025 | Afx2 Bifurcated Endograft System, Endocross Device, Torus Stent Graft System |
| Astellas Pharma US INC | $279.97 | 2021-2022 | |
| Heartflow, INC. | $256.23 | 2023 | Ffrct |
| Novartis Pharmaceuticals Corporation | $205.18 | 2024 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $204.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $177.99 | 2024-2025 | Camzyos |
| Cardiovascular Systems INC. | $172.44 | 2022 | |
| Shockwave Medical, INC | $171.31 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.89 | 2023-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $126.70 | 2019-2025 | Wainua |
| Amgen INC. | $124.99 | 2022 | |
| Zoll Circulation INC | $119.00 | 2024 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Cordis US Corp. | $64.48 | 2022 | |
| Cvrx, INC. | $61.61 | 2024 | Barostim Neo System |
| Stryker Corporation | $48.43 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $45.89 | 2023-2024 | Sapien 3 Ultra Resilia |
| Getinge USA Sales, LLC | $26.53 | 2023 | Cardiosave Hybrid, Type B Plug |
| Terumo Medical Corporation | $25.39 | 2024 | Glidesheath Slender, Metacross Otw |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Hasnie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.